Abstract

This financial analysis evaluates the performance of pharmaceutical and information technology (IT) group companies focused on Annual Return, EBIT/Total Revenue, and EPS metrics from the year between 2019 and 2022. This analysis shows positive growth in annual returns for the pharmaceutical group of Merck & Co., Inc. MRK and Pfizer Inc. PFE, where PFE consistently outperforms MRK. In the IT sector, Microsoft Corporation MSFT and Apple Inc. AAPL also show substantial growth in annual returns, where AAPL is leading while MSFT is more stable than AAPL. EPS trends highlight profitability where AAPL was leading in the IT sector. Correlations between annual return and EBIT/Total Revenue are positive for both sectors, which indicates a connection between profitability and returns. This analysis suggests that the IT sector tends to perform higher and more consistent profitability and investment returns than pharmaceuticals, providing valuable insights for investors and stakeholders to inform their financial decisions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call